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Introduction
Understanding the tumor microenvironment is essential for the delivery of personalized cancer treatment (1) (2) (3) . Hypoxia, resulting from an imbalance between oxygen delivery and consumption, is an important component of the tumor microenvironment that influences the response to both radiotherapy and chemotherapy (2, 4, 5) . Tumor hypoxia is a well-established cause of treatment resistance, and adversely affects the prognosis of head and neck squamous cell carcinoma (HNSCC) (6) . Furthermore, targeting tumor hypoxia has been validated as a therapeutic strategy in HNSCC (6, 7) , and its modification during standard radiotherapy can improve outcomes in terms of loco-regional control, disease-specific survival and overall survival (8) .
Historically, the low oxygen tension associated with tumors was considered to be a consequence of chronic or diffusion-limited hypoxia (9) , and acute or perfusion-limited hypoxia (10) . It is now clear that this is an oversimplification, and that the tumor microenvironment is highly dynamic and contains subpopulations of cancer cells exposed to continuously changing gradients of oxygen, nutrients and pH (11) . These microenvironmental components can promote genomic instability within cancer cells, providing an overall selective advantage for malignant growth (12) . For example, tumors may contain cells that have been differentially exposed to hypoxia for minutes to hours and then re-oxygenated (13) (14) (15) . This process can recur, leading to 'cycling' hypoxia (16) (17) (18) . Cycling hypoxia arises from variations in red blood cell (RBC) flux through the abnormal tumor vasculature (16, 18, 19) . Several factors may contribute to such fluctuations, including arteriolar vasomotion (20, 21) , rapid vascular modeling (22) , disorganized vascular hierarchy (23, 24) or increased transcapillary permeability (25).
Experimental evidence suggests that hypoxia and anoxia can alter tumor cell cycle checkpoint control and the sensing and repair of DNA damage (12, 26, 27) . Pre-clinical studies have shown that the homologous recombination DNA repair pathway is suppressed by chronic hypoxia, whereas DNA damageassociated checkpoint cell cycle arrest and non-homologous end joining are stimulated by acute hypoxia (12, 27) . These factors lead to radio-resistance, decreased delivery of cytotoxics, and increased metastatic potential.
Therefore, detecting the magnitude and distribution of acutely and chronically hypoxic tumor cell subpopulations may determine their prognostic and predictive value in HNSCC and help selection of optimal therapeutic strategies (2).
Advances in imaging techniques can now provide a means of defining noninvasive quantitative biomarkers to inform on biologically relevant structurefunction relationships in tumors, enabling their accurate detection, an understanding of their behavior, and report on response to treatment. One such approach, intrinsic susceptibility MRI (IS-MRI), involves quantitation of the transverse relaxation rate R 2 *, which is sensitive to the concentration of paramagnetic deoxyhemoglobin within the vascular compartment of tissues.
Compared to most normal tissues, tumors typically exhibit relatively fast R 2 * values, a consequence of the high concentration of deoxygenated RBCs within the typically chaotic and unstable microcirculation. However, the strength of the correlation between tissue R 2 * and oxygen partial pressure, measured in situ using oxygen probes, or via immunohistochemical detection of reduced 2-nitroimidazole adducts, has been reported to be at best moderate (28) . This is likely due to the dependence of R 2 * on a number of physiological factors, including blood volume, hematocrit and vessel calibre (28) (29) (30) . However, variations in these parameters can be greatly compensated for, and data interpretation simplified, through assessing modulation of R 2 * with, for example, hyperoxic gas challenge, or injection of vascular contrast agents. It is also possible to temporally monitor changes in R 2 * using continuous IS-MRI measurements, which have been exploited pre-clinically to non-invasively image cycling hypoxia at high spatial and temporal resolution in tumors propagated in mice (31) (32) (33) .
In this study, IS-MRI was initially used to measure spontaneous R 2 * fluctuations in mice bearing HNSCC xenografts on a clinical 3T MRI scanner, and pathological correlates sought. Subsequently, the preclinical IS-MRI methodology was translated to a clinical pilot study of patients with locally advanced HNSCC, also imaged at 3T.
Materials and Methods

Pre-clinical Imaging:
Experiments were performed in compliance with Home Office licenses issued Tumors were imaged at volumes of ~500 mm as previously described (38). Vessel density was then assessed through detection of CD31 on the same sections using rat anti-mouse CD31
antibodies (BD Biosciences, Oxford, UK, 1:100) and Alexa 546-conjugated goat anti-rat IgG antibody (Invitrogen, 1:500). Tumor hypoxia, perfusion and vessel density were quantified as previously described (38).
Clinical Imaging:
Ten patients with untreated, histologically proven HNSCC were scanned twice 
Signal processing:
R 2 * maps were calculated for each time point using MatLab (MathWorks, Natick, MA), and the gradient echo image signal intensity decay was fitted on a voxel-wise basis to a mono-exponential model using a least-squares fit
method (30). A non-rigid image registration (MIRT -Medical Image
Registration Toolbox for Matlab, sum-of-squared-differences similarity measure (39)) was performed to correct for any motion in the clinical examinations. The shortest echo time (TE = 4.6 ms) images were used to calculate deformation matrices, which were subsequently applied to corresponding R 2 * maps (R 2 *(t) MOCO ). The residual motion was inspected using cine loops and image intensity time traces S(t) MOCO generated for each tumor volume of interest (50 mm line profiles in two orthogonal directions). 
Statistical analysis:
The Shapiro-Wilk test was used to evaluate distribution normality of measured Statistical analysis was performed using the Matlab Statistics Toolbox.
Results
Pre-clinical findings:
The (Table 1 ). Figure   2B illustrates the spatial distribution of fluctuations in the xenograft cohort. Figure S6 ).
Treatment outcomes
Clinical outcomes are presented in Table 2 
